Table 11 (abstract P203). Demographic characteristics, seroprotection rates and mean anti-HAV IgG titers for the SLE and the control group

Study sample, n

21

76

0.9*

Age, years, mean (SD)

11.3 (2.3)

10 (2.7)

0.8*

 female

20 (95%)

72 (95%)

0.6+

 male

1 (5%)

4 (5%)

Fully vaccinated

16 (71%)

62 (83%)

0.7+

Partially vaccinated (other than HAV)

5 (29%)

14 (17%)

 -HAVRIX

34 (81%)

119 (78%)

0.84+

 -VAQTA

8 (19%)

33 (22%)

Mean interval between doses (months)

19

23

0.3*

Mean time from last dose to sampling (years)

6

5.4

0.7*

Seroprotection rate at diagnosis (%)

95

98

0.4+

Seroprotection rate at 1 year (%)

90

97

0.1+

Seroprotection rate at 3 years (%)

86

96

0.07+

Mean IgG titers at diagnosis (mIU/ml)

167

249

<0.01*

Mean anti HAV IgG titers at 1 year

131

218

Mean anti HAV IgG titers at 3 years

121

202